Literature DB >> 10884413

On the kinetics of distamycin binding to its target sites on duplex DNA.

R Baliga1, D M Crothers.   

Abstract

Distamycin A is a well known polyamide antibiotic that can bind in the minor groove of duplex DNA primarily at AT-rich sequences both as a monomer or as a side-by-side antiparallel dimer. The association phase of the distamycin binding reaction has not been studied in either of its binding modes, because of the lack of an adequate UV or CD signal at the low concentrations needed to monitor the fast bimolecular reaction. We report a significant increase in fluorescence amplitude, accompanied by a small red shift, on binding distamycin to its specific target sites. This signal can be used to monitor drug binding in steady-state and time-resolved processes. Distamycin shows extremely fast association with the 1:1 binding site, with a bimolecular rate of 7 x 10(7) M(-1) small middle dots(-1) and also fairly rapid dissociation ( approximately 3 s(-1)). When DNA is in excess, there is a slow component in the association reaction whose rate decreases strongly with increasing DNA concentration. Binding of the drug to the 2:1 site occurs in two distinct steps: fast, sequential binding of each drug molecule to the DNA with a bimolecular rate comparable to that at the 1:1 site, followed by a slow ( approximately 4 s(-1)) equilibration to the final population. Dissociation from the 2:1 site is approximately 40-fold slower than from the 1:1 site. This study provides the groundwork for analysis of the binding kinetics of longer polyamides and covalently linked polyamides that have recently been shown to inhibit transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884413      PMCID: PMC16627          DOI: 10.1073/pnas.97.14.7814

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Sequence-specific DNA recognition by polyamides.

Authors:  P B Dervan; R W Bürli
Journal:  Curr Opin Chem Biol       Date:  1999-12       Impact factor: 8.822

2.  DNA minor groove recognition by bis-benzimidazole analogues of Hoechst 33258: insights into structure-DNA affinity relationships assessed by fluorescence titration measurements.

Authors:  C E Bostock-Smith; M S Searle
Journal:  Nucleic Acids Res       Date:  1999-04-01       Impact factor: 16.971

3.  Structure and dynamics of distamycin A with d(CGCAAATTGGC):d(GCCAATTTGCG) at low drug:DNA ratios.

Authors:  J G Pelton; D E Wemmer
Journal:  J Biomol Struct Dyn       Date:  1990-08

4.  DNA-induced distamycin A fluorescence.

Authors:  J C Stockert; P Del Castillo; J L Bella
Journal:  Histochemistry       Date:  1990

5.  Studies of the binding of actinomycin and related compounds to DNA.

Authors:  W Müller; D M Crothers
Journal:  J Mol Biol       Date:  1968-07-28       Impact factor: 5.469

6.  [Formation kinetics of the AT-specific complex: DNA-distamycin A].

Authors:  I V Smirnov; A I Poletaev
Journal:  Biofizika       Date:  1978 Mar-Apr

7.  Netropsin, a DNA-binding oligopeptide structural and binding studies.

Authors:  H M Berman; S Neidle; C Zimmer; H Thrum
Journal:  Biochim Biophys Acta       Date:  1979-01-26

8.  Kinetics of the interaction between echinomycin and deoxyribonucleic acid.

Authors:  K R Fox; L P Wakelin; M J Waring
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

9.  A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin.

Authors:  M Coll; C A Frederick; A H Wang; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  Structural characterization of a 2:1 distamycin A.d(CGCAAATTGGC) complex by two-dimensional NMR.

Authors:  J G Pelton; D E Wemmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more
  8 in total

1.  Using pyrene-labeled HIV-1 TAR to measure RNA-small molecule binding.

Authors:  Kenneth F Blount; Yitzhak Tor
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

2.  Molecular recognition of DNA by ligands: roughness and complexity of the free energy profile.

Authors:  Wenwei Zheng; Attilio Vittorio Vargiu; Attlio Vittorio Vargiu; Mary A Rohrdanz; Paolo Carloni; Cecilia Clementi
Journal:  J Chem Phys       Date:  2013-10-14       Impact factor: 3.488

3.  C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.

Authors:  Wang-Yong Yang; Boris Breiner; Serguei V Kovalenko; Chi Ben; Mani Singh; Shauna N LeGrand; Qing-Xiang Amy Sang; Geoffrey F Strouse; John A Copland; Igor V Alabugin
Journal:  J Am Chem Soc       Date:  2009-08-19       Impact factor: 15.419

4.  Molecular motions in drug design: the coming age of the metadynamics method.

Authors:  Xevi Biarnés; Salvatore Bongarzone; Attilio Vittorio Vargiu; Paolo Carloni; Paolo Ruggerone
Journal:  J Comput Aided Mol Des       Date:  2011-02-17       Impact factor: 3.686

5.  Groove-binding unsymmetrical cyanine dyes for staining of DNA: dissociation rates in free solution and electrophoresis gels.

Authors:  Maja Eriksson; H Jonas Karlsson; Gunnar Westman; Björn Akerman
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

6.  Dissociation of minor groove binders from DNA: insights from metadynamics simulations.

Authors:  Attilio Vittorio Vargiu; Paolo Ruggerone; Alessandra Magistrato; Paolo Carloni
Journal:  Nucleic Acids Res       Date:  2008-09-18       Impact factor: 16.971

Review 7.  Targeting Transcription Factors for Cancer Treatment.

Authors:  Mélanie Lambert; Samy Jambon; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Molecules       Date:  2018-06-19       Impact factor: 4.411

8.  Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals.

Authors:  Xian Zhang; Ling Chen; Xun-Chang Fei; Yin-Sheng Ma; Hong-Wen Gao
Journal:  BMC Mol Biol       Date:  2009-02-25       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.